QU
Uniqure
QURE·NASDAQAmsterdam NLFounded 2012500 employees
Small CapbiotechPublicRare DiseaseNeurology
Platform: AAV Gene
Market Cap
$1.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (QURE)
Loading QURE stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Mirilucimab | QUR-5712 | NDA/BLA | 2 | JAK2 | RB | ||
| Nidarelsin | QUR-7402 | Phase 2/3 | 2 | RET | Ewing SarcomaThymoma |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)